Horizon Investment Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,099
Closed -$245K 106
2016
Q3
$245K Sell
3,099
-57,197
-95% -$4.65M 0.12% 92
2016
Q2
$5.03M Sell
60,296
-10,394
-15% -$922K 2.54% 10
2016
Q1
$6.49M Sell
70,690
-4,303
-6% -$388K 2.97% 8
2015
Q4
$7.59M Buy
74,993
+6,505
+9% +$677K 3.25% 6
2015
Q3
$6.72M Buy
68,488
+12,388
+22% +$1.38M 3.23% 6
2015
Q2
$6.57M Buy
56,100
+50,306
+868% +$5.5M 2.63% 10
2015
Q1
$569K Buy
5,794
+2,330
+67% +$237K 0.24% 59
2014
Q4
$327K Buy
+3,464
New +$358K 0.15% 94

Other funds holding GILD

Horizon Investment Services's GILD Position: Q4 2016 in Review

Horizon Investment Services sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,099 shares — an estimated $245K sold.

Horizon Investment Services first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $7.59M in Q4 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Horizon Investment Services reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Horizon Investment Services sold 3,099 Gilead Sciences shares in Q4 2016, an estimated $245K.
  • Horizon Investment Services first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
  • Horizon Investment Services's Gilead Sciences position peaked at $7.59M in Q4 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Horizon Investment Services's 13F filing for Q4 2016, filed 15 Feb 2017.